nach oben

Social Psychiatry and Psychiatric Epidemiology

Erschienen in:

22.06.2016 | Editorial

Novel methods in psychiatric epidemiology

verfasst von: Ulrich Reininghaus, Katherine M. Keyes, Craig Morgan

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Excerpt

In January 2014, SPPE began to publish a series of reviews, editorials, and commentaries with the goal of synthesising evidence and providing a platform for discussing and advancing the state of the art in social psychiatry and psychiatric epidemiology. More than 2 years into these series, it is useful to take stock, look back, and provide an overview of what comes next. …

Keyes KM, Susser E (2014) The expanding scope of psychiatric epidemiology in the 21st century. Soc Psychiatry Psychiatr Epidemiol 49(10):1521–1524. doi:10.1007/s00127-014-0938-5 CrossRefPubMedPubMedCentral

Reininghaus U, Morgan C (2014) Integrated models in psychiatry: the state of the art. Soc Psychiatry Psychiatr Epidemiol 49(1):1–2. doi:10.1007/s00127-013-0807-7 CrossRefPubMed

Iyegbe C, Campbell D, Butler A, Ajnakina O, Sham P (2014) The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research. Soc Psychiatry Psychiatr Epidemiol 49(2):169–182. doi:10.1007/s00127-014-0823-2 CrossRefPubMed

Uher R (2014) Gene-environment interactions in common mental disorders: an update and strategy for a genome-wide search. Soc Psychiatry Psychiatr Epidemiol 49(1):3–14. doi:10.1007/s00127-013-0801-0 CrossRefPubMed

Belsky DW, Suppli NP, Israel S (2014) Gene-environment interaction research in psychiatric epidemiology: a framework and implications for study design. Soc Psychiatry Psychiatr Epidemiol 49(10):1525–1529. doi:10.1007/s00127-014-0954-5 CrossRefPubMedPubMedCentral

Kirkbride JB (2014) The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for gXe research. Soc Psychiatry Psychiatr Epidemiol 49(10):1531–1534. doi:10.1007/s00127-014-0961-6 CrossRefPubMedPubMedCentral

Pishva E, Kenis G, van den Hove D, Lesch KP, Boks MP, van Os J, Rutten BP (2014) The epigenome and postnatal environmental influences in psychotic disorders. Soc Psychiatry Psychiatr Epidemiol 49(3):337–348. doi:10.1007/s00127-014-0831-2 CrossRefPubMed

Kundakovic M (2014) Postnatal risk environments, epigenetics, and psychosis: putting the pieces together. Soc Psychiatry Psychiatr Epidemiol 49(10):1535–1536. doi:10.1007/s00127-014-0927-8 CrossRefPubMed

Baumeister D, Russell A, Pariante CM, Mondelli V (2014) Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors. Soc Psychiatry Psychiatr Epidemiol 49(6):841–849. doi:10.1007/s00127-014-0887-z CrossRefPubMed

10.

Uddin M, Diwadkar VA (2014) Inflammation and psychopathology: what we now know, and what we need to know. Soc Psychiatry Psychiatr Epidemiol 49(10):1537–1539. doi:10.1007/s00127-014-0934-9 CrossRefPubMed

11.

Bentall RP, de Sousa P, Varese F, Wickham S, Sitko K, Haarmans M, Read J (2014) From adversity to psychosis: pathways and mechanisms from specific adversities to specific symptoms. Soc Psychiatry Psychiatr Epidemiol 49(7):1011–1022. doi:10.1007/s00127-014-0914-0 CrossRefPubMed

12.

Freeman D, Garety P (2014) Advances in understanding and treating persecutory delusions: a review. Soc Psychiatry Psychiatr Epidemiol 49(8):1179–1189. doi:10.1007/s00127-014-0928-7 CrossRefPubMedPubMedCentral

13.

Beards S, Fisher HL (2014) The journey to psychosis: an exploration of specific psychological pathways. Soc Psychiatry Psychiatr Epidemiol 49(10):1541–1544. doi:10.1007/s00127-014-0953-6 CrossRefPubMed

14.

Akdeniz C, Tost H, Meyer-Lindenberg A (2014) The neurobiology of social environmental risk for schizophrenia: an evolving research field. Soc Psychiatry Psychiatr Epidemiol 49(4):507–517. doi:10.1007/s00127-014-0858-4 CrossRefPubMed

15.

Bebbington P (2015) Categories, continua and the growth of psychiatric knowledge. Soc Psychiatry Psychiatr Epidemiol 50(4):507–510. doi:10.1007/s00127-015-1033-2 CrossRefPubMed

16.

Bohnke JR, Croudace TJ (2015) Factors of psychological distress: clinical value, measurement substance, and methodological artefacts. Soc Psychiatry Psychiatr Epidemiol. doi:10.1007/s00127-015-1022-5 PubMedCentral

17.

Carragher N, Krueger RF, Eaton NR, Slade T (2015) Disorders without borders: current and future directions in the meta-structure of mental disorders. Soc Psychiatry Psychiatr Epidemiol 50(3):339–350. doi:10.1007/s00127-014-1004-z CrossRefPubMed

18.

Eaton NR, Rodriguez-Seijas C, Carragher N, Krueger RF (2015) Transdiagnostic factors of psychopathology and substance use disorders: a review. Soc Psychiatry Psychiatr Epidemiol 50(2):171–182. doi:10.1007/s00127-014-1001-2 CrossRefPubMed

19.

Goldberg D (2015) Psychopathology and classification in psychiatry. Soc Psychiatry Psychiatr Epidemiol 50(1):1–5. doi:10.1007/s00127-014-0924-y CrossRefPubMed

20.

Reininghaus U, Bohnke JR, Hosang G, Farmer A, Burns T, McGuffin P, Bentall RP (2016) Evaluation of the validity and utility of a transdiagnostic psychosis dimension encompassing schizophrenia and bipolar disorder. Br J Psychiatry. doi:10.1192/bjp.bp.115.167882 PubMedCentral

21.

Reininghaus U, Priebe S, Bentall RP (2013) Testing the psychopathology of psychosis: evidence for a general psychosis dimension. Schizophr Bull 39(4):884–895. doi:10.1093/schbul/sbr182 CrossRefPubMed

22.

Shevlin M, McElroy E, Bentall RP, Reininghaus U, Murphy J (2016) The psychosis continuum: testing a bifactor model of psychosis in a general population sample. Schizophr Bull. doi:10.1093/schbul/sbw067 PubMed

23.

Beesdo-Baum K, Knappe S, Asselmann E, Zimmermann P, Bruckl T, Hofler M, Behrendt S, Lieb R, Wittchen HU (2015) The ‘Early Developmental Stages of Psychopathology (EDSP) study’: a 20-year review of methods and findings. Soc Psychiatry Psychiatr Epidemiol 50(6):851–866. doi:10.1007/s00127-015-1062-x CrossRefPubMed

24.

Fergusson DM, Boden JM, Horwood LJ (2015) Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study. Soc Psychiatry Psychiatr Epidemiol 50(9):1317–1326. doi:10.1007/s00127-015-1070-x CrossRefPubMed

25.

Harding S, Read UM, Molaodi OR, Cassidy A, Maynard MJ, Lenguerrand E, Astell-Burt T, Teyhan A, Whitrow M, Enayat ZE (2015) The determinants of young adult social well-being and health (DASH) study: diversity, psychosocial determinants and health. Soc Psychiatry Psychiatr Epidemiol 50(8):1173–1188. doi:10.1007/s00127-015-1047-9 CrossRefPubMedPubMedCentral

26.

Harper S, Towers-Evans H, MacCabe J (2015) The aetiology of schizophrenia: what have the Swedish Medical Registers taught us? Soc Psychiatry Psychiatr Epidemiol 50(10):1471–1479. doi:10.1007/s00127-015-1081-7 CrossRefPubMed

27.

Hasin DS, Grant BF (2015) The national epidemiologic survey on alcohol and related conditions (NESARC) Waves 1 and 2: review and summary of findings. Soc Psychiatry Psychiatr Epidemiol 50(11):1609–1640. doi:10.1007/s00127-015-1088-0 CrossRefPubMed

28.

Poulton R, Moffitt T, Silva P (2015) The Dunedin Multidisciplinary Health and Development Study: overview of the first 40 years, with an eye to the future. Soc Psychiatry Psychiatr Epidemiol. doi:10.1007/s00127-015-1048-8 PubMedPubMedCentral

29.

Hall W (2015) Erratum to: challenges in minimizing the adverse effects of cannabis use after legalization. Soc Psychiatry Psychiatr Epidemiol 50(9):1327. doi:10.1007/s00127-015-1117-z CrossRefPubMed

30.

Hall W (2015) Challenges in minimizing the adverse effects of cannabis use after legalization. Soc Psychiatry Psychiatr Epidemiol 50(7):1013–1015. doi:10.1007/s00127-015-1067-5 CrossRefPubMed

31.

Brumley LD, Jaffee SR (2016) Defining and distinguishing promotive and protective effects for childhood externalizing psychopathology: a systematic review. Soc Psychiatry Psychiatr Epidemiol. doi:10.1007/s00127-016-1228-1 PubMed

32.

Costello EJ, Copeland W, Angold A (2016) The Great Smoky Mountains Study: developmental epidemiology in the southeastern United States. Soc Psychiatry Psychiatr Epidemiol 51(5):639–646. doi:10.1007/s00127-015-1168-1 CrossRefPubMed

33.

Laurens KR, Cullen AE (2016) Toward earlier identification and preventative intervention in schizophrenia: evidence from the London Child Health and Development Study. Soc Psychiatry Psychiatr Epidemiol 51(4):475–491. doi:10.1007/s00127-015-1151-x CrossRefPubMed

34.

Lewis G, Jones PB, Goodyer IM (2016) The ROOTS study: a 10-year review of findings on adolescent depression, and recommendations for future longitudinal research. Soc Psychiatry Psychiatr Epidemiol 51(2):161–170. doi:10.1007/s00127-015-1150-y CrossRefPubMed

35.

Malla A, Iyer S, McGorry P, Cannon M, Coughlan H, Singh S, Jones P, Joober R (2016) From early intervention in psychosis to youth mental health reform: a review of the evolution and transformation of mental health services for young people. Soc Psychiatry Psychiatr Epidemiol 51(3):319–326. doi:10.1007/s00127-015-1165-4 CrossRefPubMed

36.

Yung AR (2016) Youth services: the need to integrate mental health, physical health and social care: commentary on Malla et al.: from early intervention in psychosis to youth mental health reform: a review of the evolution and transformation of mental health services for young people. Soc Psychiatry Psychiatr Epidemiol 51(3):327–329. doi:10.1007/s00127-016-1195-6 CrossRefPubMed

37.

Galbraith S, Bowden J, Mander A (2014) Accelerated longitudinal designs: an overview of modelling, power, costs and handling missing data. Stat Methods Med Res. doi:10.1177/0962280214547150 PubMed

38.

Valmaggia L, Day F, Rus-Calafell M (2016) Using virtual reality to investigate psychological processes and mechanisms associated with the onset and maintenance of psychosis: a systematic review. Soc Psychiatry Psychiatr Epidemiol 51(7). doi:10.1007/s00127-016-1245-0

39.

Gayer-Anderson C (2016) The application of virtual reality technology to understanding psychosis. Commentary on Valmaggia et al. (2016): Using virtual reality to investigate psychological processes and mechanisms associated with the onset and maintenance of psychosis: a systematic review. Soc Psychiatry Psychiatr Epidemiol 51(7). doi:10.1007/s00127-016-1262-z

40.

Stewart R, Davis K (2016) ‘Big data’ in mental health research–current status and emerging possibilities. Soc Psychiatry Psychiatr Epidemiol; (in press)

41.

Epstein DH, Tyburski M, Craig IM, Phillips KA, Jobes ML, Vahabzadeh M, Mezghanni M, Lin JL, Furr-Holden CD, Preston KL (2014) Real-time tracking of neighborhood surroundings and mood in urban drug misusers: application of a new method to study behavior in its geographical context. Drug Alcohol Depend 134:22–29. doi:10.1016/j.drugalcdep.2013.09.007 CrossRefPubMed

42.

Myin-Germeys I, Oorschot M, Collip D, Lataster J, Delespaul P, van Os J (2009) Experience sampling research in psychopathology: opening the black box of daily life. Psychol Med 39(9):1533–1547. doi:10.1017/S0033291708004947 CrossRefPubMed

43.

Shiffman S, Stone AA, Hufford MR (2008) Ecological momentary assessment. Ann Rev Clin Psychol 4:1–32CrossRef

44.

Reininghaus U, Depp CA, Myin-Germeys I (2016) Ecological interventionist causal models in psychosis: targeting psychological mechanisms in daily life. Schizophr Bull. doi:10.1093/schbul/sbv193 PubMedCentral

Titel: Novel methods in psychiatric epidemiology
verfasst von: Ulrich Reininghaus
Katherine M. Keyes
Craig Morgan
Publikationsdatum: 22.06.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Social Psychiatry and Psychiatric Epidemiology / Ausgabe 7/2016
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI: https://doi.org/10.1007/s00127-016-1251-2

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2016

Neighbourhood level social deprivation and the risk of psychotic disorders: a systematic review

Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls

Prevalence of antenatal depression and associated factors among pregnant women hospitalized in a high-risk pregnancy unit in Greece

Using virtual reality to investigate psychological processes and mechanisms associated with the onset and maintenance of psychosis: a systematic review